CIMAvax-EGF vaccine Predictor Phase IV |
14/12/2015 |
CIM |
Study of the mechanism of action of Nimotuzumab in patients with head and neck tumors |
17/02/2017 |
CIM |
EC122 HER-1 Prostate Phase I |
15/11/2016 |
CIM |
hR3 in metastatic or recurrent colorectal cancer |
22/11/2013 |
CIM |
CIMAVax EGF in Lung Cancer in PHC. Phase IV |
05/08/2014 |
CIM |
NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II |
22/04/2016 |
CIM |
Nimotuzumab inoperable esophageal epithelial tumors, Phase IV |
30/06/2016 |
CIM |
NeuroEPO in patients with Parkinson disease stage II-III |
01/02/2017 |
CIM |
CIMAvax-EGF in Bladder cancer |
11/08/2020 |
CIM |
VSSP in renal cell carcinoma |
08/04/2021 |
CIM |
Post EUA study of Itolizumab in COVID-19 |
21/03/2022 |
CIM |
Jusvinza in adult patients with Rheumatoid Arthritis from Camaguey and Eastern Provinces |
27/02/2024 |
CIGB_IB |
HeberPAG® in Mycosis Fungoides (MYFIC Study) |
2012-06-08 |
CIGB |
Safety and Pharmacology of CIGB-300 in cervical cancer (CERVIFARM-300 Study) |
2013-01-18 |
CIGB |
Biodistribution of CIGB-300 in cervical cancer (CERVIFARM-300-II Study) |
2013-01-18 |
CIGB |
Squamous cell carcinoma interferons (CECIN study) |
2013-02-01 |
CIGB |
Gamma IFN in Idiopathic Pulmonary Fibrosis. |
2011-05-17 |
CIGB |
InMuMyel I Study |
2011-05-19 |
CIGB |
GrUVen-I Study |
2011-05-03 |
CIGB |
EGFpeeling I |
2011-05-03 |
CIGB |